Mesirow Financial Investment Management, Inc.

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1469475 CHICAGO, IL

Position in VRTX

as of Mar 31, 2026 · filed Apr 21, 2026 Compact

Position Value

$302,754

+$79,248 QoQ

Shares Held

678

+37.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Mesirow Financial Investment Management, Inc. holds $3,816,862 across 11 Biotechnology names. VRTX ranks #5 (7.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	1,702	$1,315,033
2	HALO	Halozyme Therapeutics, Inc.	9,122	$589,554
3	NAMS	NewAmsterdam Pharma Co N.V.	15,430	$493,914
4	IONS	Ionis Pharmaceuticals Inc	5,460	$409,991
5	VRTX	Vertex Pharmaceuticals Inc / Ma This page	678	$302,754
6	ICCC	Immucell Corp /De/	42,481	$268,904
7	FOLD	AMICUS THERAPEUTICS, INC.	13,000	$187,980
8	CSBR	Champions Oncology, Inc.	15,800	$90,850

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$302,754	678	+37.5%	Shares	Sole	2026-04-21
2025-12-31	$223,506	493	-27.4%	Shares	Sole	2026-02-05
2025-09-30	$265,923	679	+8.8%	Shares	Sole	2025-11-12
2025-06-30	$277,804	624	-0.8%	Shares	Sole	2025-08-04
2025-03-31	$304,951	629	+10.7%	Shares	Sole	2025-05-08
2024-12-31	$228,733	568	-42.0%	Shares	Sole	2025-02-07
2024-09-30	$455,778	980	0.0%	Shares	Sole	2024-11-01
2024-06-30	$459,345	980	—	Shares	Sole	2024-08-09
No filing history on record for this holder in this stock.